Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.
about
Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizuresRapid and simultaneous quantification of levetiracetam and its carboxylic metabolite in human plasma by liquid chromatography tandem mass spectrometryPractice Update: Review of Anticonvulsant Therapy.The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications.Clinical pharmacokinetic and pharmacodynamic profile of lacosamide.Safety and tolerability of anticonvulsant medication in bipolar disorder.Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and children.Topiramate for Treatment in Patients With Migraine and Epilepsy.Alleviation of pain in painful diabetic neuropathy.Comparison of Antiepileptic Approaches in Treatment of Benzodiazepine Nonresponsive Status Epilepticus.Efficacy of Retigabine on Acute Limbic Seizures in Adult Rats.Interaction between clozapine and oxcarbazepine: a case report.A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control.Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control.Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs.Risk of pharmacokinetic interactions between antiepileptic and other drugs in older persons and factors associated with risk.Antiepileptic drugs in critically ill patients.
P2860
Q28078666-0009ED77-D9B0-4F30-AA2D-C0E45B9FE8F2Q28544793-309BC271-8CB3-40FF-8816-E0AFB104A5A6Q34518509-CCF70F52-EEA9-41D4-A934-7A56FF250644Q36909520-C42F19FD-F250-421B-9A8B-F4547A0A13E5Q38468591-7677F2EA-05E3-4C1D-98AB-A8193C228375Q38584632-A72BDCD0-FAB2-4733-A986-E062F5E25715Q38620876-1C351B70-2DEC-43B6-AC6C-4D65D54B53ADQ38819478-B9A136DE-9F9A-41E6-9B7D-3CC827580567Q38826512-1D9F61D6-31C5-4F4A-B364-B997E1D09A54Q40027459-2B772032-D425-4971-ACE3-B46205855384Q41942478-6C064CE7-113B-4CED-B1B9-33F6D359228CQ42320802-56FC9249-DB4E-443F-A0B7-B79BC23F7F22Q42372617-5D9D13BC-48C3-40B8-BFAB-240521E12266Q46365421-F269A4BA-98A6-4928-AB38-48AE96047906Q48363733-BBD82FEC-6FEF-4A73-A028-F157C4A6E176Q50145520-DC67ADDA-2F38-4116-86FB-06B504097A0EQ55190397-1A630C9B-9EBF-4265-8CD7-AB8AA47C8305
P2860
Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug interactions with the new ...... treat non-epilepsy disorders.
@en
type
label
Drug interactions with the new ...... treat non-epilepsy disorders.
@en
prefLabel
Drug interactions with the new ...... treat non-epilepsy disorders.
@en
P2860
P1476
Drug interactions with the new ...... treat non-epilepsy disorders.
@en
P2093
Philip N Patsalos
P2860
P2888
P304
P356
10.1007/S40262-013-0088-Z
P577
2013-12-01T00:00:00Z
P6179
1016461506